Procter & Gamble Stock: Analysts’ Recommendations

Most of the analysts maintained a neutral outlook on Procter & Gamble (PG) stock. Among the 24 analysts, 14 recommended a “hold,” nine recommended a “buy,” and one recommended a “sell.” Analysts maintained a target price of $92.98 per share on Procter & Gamble, which indicates an upside of 1.3% based on its closing price of $91.77 on January 11.

Procter & Gamble impressed investors with its results for the first-quarter fiscal 2019. However, sales and margin headwinds, including heightened competition, negative currency rates, and inflation in commodities, are expected to hurt the company’s second-quarter results and could restrict the upside.

Wall Street analysts maintained a neutral outlook on household and personal care product manufacturer stocks. Among the 18 analysts covering Kimberly-Clark (KMB) stock, 13 recommended a “hold,” while five recommended a “sell.” Analysts’ target price indicates a downside of 9.2% to Kimberly-Clark stock based on its closing price of $117.20 on January 11.

For Colgate-Palmolive (CL), 14 analysts recommended a “hold,” six recommended a “buy,” and two recommended a “sell.” Analysts’ consensus target price of $63.79 implies an upside of 2.3% based on its closing price of $62.10.

For Clorox (CLX), ten analysts recommended a “hold,” four recommended a “sell,” and three recommended a “buy.” Analysts have a consensus target price of $148.20 on Clorox stock, which implies a downside of 3.4% based on its closing price of $153.35 on January 11.